0001104659-16-146141.txt : 20160922
0001104659-16-146141.hdr.sgml : 20160922
20160922163934
ACCESSION NUMBER: 0001104659-16-146141
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160920
FILED AS OF DATE: 20160922
DATE AS OF CHANGE: 20160922
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Luo Mary Z.
CENTRAL INDEX KEY: 0001611156
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 161897961
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zhang Jack Y.
CENTRAL INDEX KEY: 0001611157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 161897962
MAIL ADDRESS:
STREET 1: 11570 6TH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
a4.xml
4
X0306
4
2016-09-20
0
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001611157
Zhang Jack Y.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
CEO & Chief Science Officer
0001611156
Luo Mary Z.
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
1
1
1
0
COO Chief Scientist & Chairman
Common Stock
2016-09-20
4
M
0
207350
16.753
A
1295685
D
Common Stock
2016-09-20
4
S
0
76152
20.727
D
1219533
D
Common Stock
2016-09-20
4
S
0
131198
21.3291
D
1088335
D
Common Stock
2016-09-21
4
M
0
55081
16.753
A
1143416
D
Common Stock
2016-09-21
4
S
0
54581
20.696
D
1088835
D
Common Stock
2016-09-21
4
S
0
500
21.452
D
1088335
D
Common Stock
2016-09-20
4
M
0
181768
16.753
A
934089
I
See footnote
Common Stock
2016-09-20
4
S
0
86555
20.7387
D
847534
I
See footnote
Common Stock
2016-09-20
4
S
0
95213
21.3279
D
752321
I
See footnote
Common Stock
7461594
I
See footnote
Common Stock
5000
I
See footnote
Common Stock
200000
I
See footnote
Employee Stock Option (right to buy)
16.753
2016-09-20
4
M
0
207350
0
D
2016-10-03
Common Stock
207350
55081
D
Employee Stock Option (right to buy)
16.753
2016-09-21
4
M
0
55081
0
D
2016-10-03
Common Stock
55081
0
D
Employee Stock Option (right to buy)
16.753
2016-09-20
4
M
0
181768
0
D
2016-10-03
Common Stock
181768
0
I
See footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.08 to $21.07 inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.08 to $21.53, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.21 to $21.17, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.26 to $21.50, inclusive.
The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
The shares are held of record by APCL, of which the reporting persons are the sole owners.
The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
Shares subject to the option are fully vested and immediately exercisable.
/s/ Ken Stupak, by power of attorney for Jack Y. Zhang
2016-09-22
/s/ Ken Stupak, by power of attorney for Mary Z. Luo
2016-09-22